Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Inogen Inc (INGN)

Inogen Inc (INGN)
9.93 +0.02 (+0.20%) 12:39 ET [NASDAQ]
9.87 x 105 9.94 x 110
Realtime by (Cboe BZX)
9.87 x 105 9.94 x 110
Realtime - - (-) -
Quote Overview for Mon, Feb 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
9.85
Day High
10.07
Open 9.99
Previous Close 9.91 9.91
Volume 75,121 75,121
Avg Vol 306,503 306,503
Stochastic %K 8.43% 8.43%
Weighted Alpha +6.03 +6.03
5-Day Change -0.77 (-7.19%) -0.77 (-7.19%)
52-Week Range 5.82 - 13.33 5.82 - 13.33
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 236,036
  • Shares Outstanding, K 23,818
  • Annual Sales, $ 315,660 K
  • Annual Income, $ -102,450 K
  • EBIT $ -60 M
  • EBITDA $ -42 M
  • 60-Month Beta 1.02
  • Price/Sales 0.70
  • Price/Cash Flow N/A
  • Price/Book 1.27

Options Overview Details

View History
  • Implied Volatility 89.26% ( +12.06%)
  • Historical Volatility 57.93%
  • IV Percentile 57%
  • IV Rank 34.52%
  • IV High 157.80% on 04/24/24
  • IV Low 53.14% on 01/10/25
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 94
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 855
  • Open Int (30-Day) 1,264

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.57
  • Number of Estimates 3
  • High Estimate -0.53
  • Low Estimate -0.63
  • Prior Year -1.14
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.70 +1.80%
on 02/24/25
Period Open: 11.44
12.91 -23.51%
on 01/30/25
-1.56 (-13.68%)
since 01/24/25
3-Month
8.10 +21.91%
on 12/20/24
Period Open: 9.38
12.91 -23.51%
on 01/30/25
+0.49 (+5.28%)
since 11/22/24
52-Week
5.82 +69.67%
on 02/28/24
Period Open: 9.19
13.33 -25.92%
on 08/28/24
+0.69 (+7.45%)
since 02/23/24

Most Recent Stories

More News
Inogen: Q3 Earnings Snapshot

Inogen: Q3 Earnings Snapshot

INGN : 9.93 (+0.20%)
Can HITI Stock Get a Boost From Bricks-and-Mortar Sales in Q3 Earnings?

High Tide HITI is set to release results for the third quarter of fiscal 2024 on Sept. 16 after market close.The prominent retail cannabis player posted breakeven earnings per share in the last reported...

INGN : 9.93 (+0.20%)
KIDS : 23.64 (-0.51%)
TMDX : 75.58 (+5.05%)
HITI : 2.60 (+0.39%)
Inogen: Q2 Earnings Snapshot

Inogen: Q2 Earnings Snapshot

INGN : 9.93 (+0.20%)
Inogen: Q1 Earnings Snapshot

Inogen: Q1 Earnings Snapshot

INGN : 9.93 (+0.20%)
Inogen: Q4 Earnings Snapshot

Inogen: Q4 Earnings Snapshot

INGN : 9.93 (+0.20%)
Inogen: Q3 Earnings Snapshot

Inogen: Q3 Earnings Snapshot

INGN : 9.93 (+0.20%)
Inogen: Q2 Earnings Snapshot

Inogen: Q2 Earnings Snapshot

INGN : 9.93 (+0.20%)
Inogen: Q1 Earnings Snapshot

Inogen: Q1 Earnings Snapshot

INGN : 9.93 (+0.20%)
Inogen Announces First Quarter 2023 Financial Results

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31,...

INGN : 9.93 (+0.20%)
Inogen to Report First Quarter 2023 Financial Results on May 4, 2023

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report first quarter 2023 financial results...

INGN : 9.93 (+0.20%)
Inogen to Present at 22nd Annual Needham Virtual Healthcare Conference

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside...

INGN : 9.93 (+0.20%)
Inogen Announces Appointment of Tom West to Board of Directors and Retirement of Board Member Kristen Miranda

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Tom West to Inogen’s Board of...

INGN : 9.93 (+0.20%)
Inogen to Present at KeyBanc Life Sciences & MedTech Investor Forum

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in a virtual fireside...

INGN : 9.93 (+0.20%)
Inogen: Q4 Earnings Snapshot

Inogen: Q4 Earnings Snapshot

INGN : 9.93 (+0.20%)
Inogen to Provide Strategy Update on February 27, 2023

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will host a conference call on Monday, February...

INGN : 9.93 (+0.20%)
Inogen Announces Fourth Quarter and Full Year 2022 Financial Results

Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full...

INGN : 9.93 (+0.20%)
Inogen Achieves Regulatory Milestones to Support Current and Future Products

Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it has achieved regulatory milestones in the...

INGN : 9.93 (+0.20%)
Inogen Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Within Company Expectations

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced unaudited preliminary revenue results for the fourth...

INGN : 9.93 (+0.20%)
Inogen to Present at 41st Annual J.P. Morgan Healthcare Conference

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company will be participating in the upcoming...

INGN : 9.93 (+0.20%)
Inogen to Present at Upcoming Investor Conferences in November 2022

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will present at the following investor...

INGN : 9.93 (+0.20%)

Business Summary

Inogen Inc. develops, manufactures and markets POC. POCs are used by patients who suffer from chronic respiratory conditions and need long-term oxygen therapy. POCs concentrate the air around the patient, filter out the nitrogen and other unwanted substances and deliver oxygen. The company provides oxygen...

See More

Key Turning Points

3rd Resistance Point 10.84
2nd Resistance Point 10.64
1st Resistance Point 10.27
Last Price 9.93
1st Support Level 9.70
2nd Support Level 9.50
3rd Support Level 9.13

See More

52-Week High 13.33
Fibonacci 61.8% 10.46
Last Price 9.93
Fibonacci 50% 9.57
Fibonacci 38.2% 8.69
52-Week Low 5.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

Mastering Fibonacci: The Hidden Order in Market Movements